Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 26;73(3):378-82.
doi: 10.1021/np900719u.

Engineering fluorometabolite production: fluorinase expression in Salinispora tropica Yields Fluorosalinosporamide

Affiliations

Engineering fluorometabolite production: fluorinase expression in Salinispora tropica Yields Fluorosalinosporamide

Alessandra S Eustáquio et al. J Nat Prod. .

Abstract

Organofluorine compounds play an important role in medicinal chemistry, where they are responsible for up to 15% of the pharmaceutical products on the market. While natural products are valuable sources of new chemical entities, natural fluorinated molecules are extremely rare and the pharmaceutical industry has not benefited from a microbial source of this class of compounds. Streptomyces cattleya is an unusual bacterium in that it elaborates fluoroacetate and the amino acid 4-fluorothreonine. The discovery in 2002 of the fluorination enzyme FlA responsible for C-F bond formation in S. cattleya, and its subsequent characterization, opened up for the first time the prospect of genetically engineering fluorometabolite production from fluoride ion in host organisms. As a proof of principle, we report here the induced production of fluorosalinosporamide by replacing the chlorinase gene salL from Salinispora tropica with the fluorinase gene flA.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Biosynthesis of fluorometabolites by Streptomyces cattleya, (top), of salinosporamide A by Salinispora tropica (bottom) and fluorosalinosporamide engineering (middle).
Figure 2
Figure 2
Fluorinase expression in S. tropica. (A) The chlorinase gene salL was chromosomally replaced with fluorinase flA and the apramycin resistance/oriT cassette from pIJ773 (ApraR) using PCR targeting., flA is thus under control of the natural salL promoter and ribosome binding site. The targeted locus of the wild-type (WT) and mutant (MT) chromosomes is shown for comparison. (B) The authenticity of mutants was confirmed by PCR. (C) flA transcription was analyzed by semi-quantitative RT-PCR. 16S rRNA was used as control of cDNA quality and integrity. The negative control with RNA instead of cDNA samples confirms the absence of genomic DNA contamination.
Figure 3
Figure 3
HPLC-MS analysis of culture extracts of S. tropica wild-type and the flA+ salL- mutant grown in A1 seawater-based media, and of the mutant grown in A1 seawater-based media pH 6.0 to which 2 mM potassium fluoride was added at day 2 (+ KF). HPLC was monitored at 210 nm.
Figure 4
Figure 4
19F-NMR analysis of S. tropica salL- flA+ culture extracts. The upper trace shows the decoupled 19F{1H}-NMR spectrum of the organic fraction of the extract, whereas the lower trace is the proton coupled 19F-NMR spectrum. In all, five fluorometabolites were detected with the major product as fluorosalinosporamide (-220.7 ppm).
Figure 5
Figure 5
1H/19F-HMBC (500 MHz, CDCl3) correlation spectra. The upper trace is the spectrum of a reference sample of fluorosalinosporamide. The lower spectrum is a focused section illustrating fluorosalinosporamide in the S. tropica salL- flA+ extract grown in limiting fluoride. The fluorine atom is coupling to three sets of protons with chemical shifts consistent with the FCH2CH2CH-R fragment.
Figure 6
Figure 6
Simulation of the 19F-NMR spectrum of fluorosalinosporamide (upper trace) compared to the experimental spectrum (lower trace). J(1H,19F) = 47.0 Hz (2 equivalent H), J(1H,19F) = 28.8 and 24.3 Hz (2 non-equivalent diastereotopic H).

References

    1. Harper DB, O'Hagan D. Nat Prod Rep. 1994;11:123–133. - PubMed
    1. Neumann CS, Fujimori DG, Walsh CT. Chem Biol. 2008;15:99–109. - PubMed
    1. Blasiak LC, Drennan CL. Acc Chem Res. 2009;42:147–155. - PMC - PubMed
    1. Dong C, Huang F, Deng H, Schaffrath C, Spencer JB, O'Hagan D, Naismith JH. Nature. 2004;427:561–565. - PubMed
    1. O'Hagan D, Schaffrath C, Cobb SL, Hamilton JT, Murphy CD. Nature. 2002;416:279. - PubMed

Publication types

MeSH terms